Stock Rating Downgrade
During the last several trading days the Value Trend Rating for Adverum Biotechnologies Inc (NASDAQ: ADVM) weakened from C to D reflecting eroding fundamentals and low Appreciation Potential.
Recent Price Action
Adverum Biotechnologies Inc (NASDAQ: ADVM) stock closed at $6.59 on 10/1/24 after a large decline of -6.1%. NORMAL trading volume accompanied the decline. The stock has declined -4.2% during the last week and has been extremely weak relative to the market over the last nine months.
Current PriceTarget Research Rating
ADVM is expected to continue to be a modest Value Eraser reflecting capital returns that are forecasted to fall short of the cost of capital.
Adverum Biotechnologies has a current Value Trend Rating of D (Negative). This rating combines inconsistent signals from two proprietary PTR measures of a stock’s attractiveness. Adverum Biotechnologies has a neutral Appreciation Score of 59 but a poor Power Rating of 23, leading to the Negative Value Trend Rating.
Be the first to comment